One-Year Outcomes in a Supervised Program of Swallowable Intragastric Balloon—Analysis of 486 Patients in a High-Volume Bariatric Centre in Malaysia

• Published in: Obesity surgery 2024-09, Vol.34 (9), p.3366-3371
• Main Authors: Kosai, Nik Ritza, Ali, Aishath Azna, Ghita, Ryan, Muthkumaran, Guhan, Ali, Ismail, Loo, Guo Hou, Hayati, Firdaus
• Format: Article
• Language: English
• Subjects: Adult; Anesthesia; Bariatric Surgery - methods; Body Mass Index; Catheters; Deglutition; Drug dosages; Endoscopy; Female; Gastric Balloon; Gastrointestinal surgery; Hospitals; Hospitals, High-Volume; Humans; Malaysia - epidemiology; Male; Medicine; Medicine & Public Health; Metabolism; Middle Aged; Nutrition research; Obesity; Obesity, Morbid - surgery; Obesity, Morbid - therapy; Original Contributions; Overweight; Prospective Studies; Surgery; Treatment Outcome; Weight control; Weight Loss
• ISSN: 0960-8923; 1708-0428; 1708-0428
• DOI: 10.1007/s11695-024-07414-y

Introduction The swallowable intragastric balloon (IGB) has recently emerged as a popular alternative for weight loss in Malaysia. It can reduce total body weight loss (TBWL) by 6–15%. We aim to observe positive weight loss up to a year after the swallowable IGB is implanted. Methods A total of 486 consecutive patients with overweight or obesity who underwent swallowable IGB insertion were included in this prospective data collection. Results Out of 486 patients, 404 patients (83%) had complete data at the end of 4 and 12 months. Patients included in the study had a starting mean body mass index of 35.3 ± 7.2 kg/m 2 which decreased to 31.5 ± 5.7 kg/m 2 ( p